Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01547741
What this trial is testing

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 4,242
Testing effectiveness (Phase 2)UnknownNCT04247633
What this trial is testing

High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)

Who this might be right for
Breast Cancer
Samsung Medical Center 578
Not applicableNot Yet RecruitingNCT07187674
What this trial is testing

The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Harbin Medical University 20
Not applicableActive Not RecruitingNCT06441474
What this trial is testing

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women

Who this might be right for
Breast Cancer Female
University of Colorado, Denver 726
Not applicableActive Not RecruitingNCT04763915
What this trial is testing

Improving Care After Inherited Cancer Testing

Who this might be right for
Inherited Cancer SyndromeProstate CancerColorectal Cancer+2 more
Vanderbilt-Ingram Cancer Center 720
Not applicableStudy completedNCT06005025
What this trial is testing

Examination of the Effect of Counselling and Follow-up After Breast Cancer Awareness Education

Who this might be right for
Breast CancerNurseEducation+2 more
Tarsus University 160
Not applicableLooking for participantsNCT05667532
What this trial is testing

The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04293393
What this trial is testing

Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients

Who this might be right for
Early Breast Cancer
Spanish Breast Cancer Research Group 200
Not applicableStudy completedNCT04708093
What this trial is testing

Whole Body Vibration Training and Breast Cancer Risk Factors

Who this might be right for
Breast Cancer
Cairo University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Not applicableEnrolling By InvitationNCT04996316
What this trial is testing

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Who this might be right for
Breast Carcinoma
OHSU Knight Cancer Institute 1,141
Not applicableStudy completedNCT00667121
What this trial is testing

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Who this might be right for
Breast CancerDepressionHot Flashes+1 more
Mayo Clinic 88
Not applicableLooking for participantsNCT07214532
What this trial is testing

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement)
Natera, Inc. 725
Not applicableActive Not RecruitingNCT04261972
What this trial is testing

Cell-free DNA in Hereditary And High-Risk Malignancies 1

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,416
Testing effectiveness (Phase 2)Study completedNCT00090857
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 49
Not applicableActive Not RecruitingNCT03546972
What this trial is testing

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationDuctal Breast Carcinoma In Situ+3 more
M.D. Anderson Cancer Center 51
Not applicableUnknownNCT02992769
What this trial is testing

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

Who this might be right for
Breast Cancer Female
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Not applicableStudy completedNCT01399359
What this trial is testing

Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,023
Testing effectiveness (Phase 2)Study completedNCT00407888
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-positive Breast CancerStage IA Breast Cancer+6 more
University of Washington 60
Not applicableActive Not RecruitingNCT02494869
What this trial is testing

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Who this might be right for
High Risk for Developing Breast Cancer
Memorial Sloan Kettering Cancer Center 75
Next Page